CTLA4 and colorectal carcinoma: This technique is currently being investigated for multiple prodrugs using primarily Salmonella spp. and Clostridium spp. Most notably, for the use against CRC, the S. typhimurium VNP20009, mentioned previously, was further modified to express E. coli cytosine deaminase and named TAPET-CD [130].